Skip to main content

Moors & Cabot, Inc.

Position in BMY — Bristol Myers Squibb Co

CIK 1607239 BOSTON, MA

Position in BMY

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$3,628,158
-$486,338 QoQ
Shares Held
62,967
-7.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#637
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Jun 30, 2020
CallValue
$1,000
CallShares
1,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. BMY ranks #8 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 BMY
Bristol Myers Squibb Co
This page
62,967 $3,628,158

All Filings in BMY

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,628,158 62,967
2026-03-31 $4,114,496 67,840
2025-12-31 $4,056,288 75,200
2025-09-30 $3,103,556 68,815
2025-06-30 $3,423,099 73,949
2025-03-31 $4,731,787 77,583
2024-12-31 $5,046,792 89,229
2024-09-30 $4,017,662 77,651
2024-06-30 $3,534,410 85,105
2024-03-31 $5,476,633 100,989
2023-12-31 $5,095,698 99,312
2023-09-30 $6,175,107 106,394
2023-06-30 $6,894,577 107,812
2023-03-31 $7,350,949 106,059
2022-12-31 $7,497,477 104,204
2022-09-30 $7,209,876 101,419
2022-06-30 $7,746,739 100,607
2022-03-31 $7,569,194 103,645
2021-12-31 $6,353,776 101,905
2021-09-30 $6,227,169 105,242
2021-06-30 $6,907,250 103,371
2021-03-31 $7,092,339 112,345
2020-12-31 $7,375,304 118,899
2020-09-30 $6,943,659 115,171
2020-06-30 $6,607,179 112,367
2020-06-30 $1,000 1,000
2020-03-31 $5,493,121 98,549